Literature DB >> 19004025

Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma.

Yan-Bin Feng1, De-Chen Lin, Zhi-Zhou Shi, Xiao-Chun Wang, Xiao-Ming Shen, Yu Zhang, Xiao-Li Du, Man-Li Luo, Xin Xu, Ya-Ling Han, Yan Cai, Zi-Qiang Zhang, Qi-Min Zhan, Ming-Rong Wang.   

Abstract

PLK1 is essential for the maintenance of genomic stability during mitosis. In our study, we found that overexpression of PLK1 was an independent prognostic factor (RR=4.253, p=0.020) and significantly correlated with survivin, an antiapoptotic protein, in esophageal squamous cell carcinoma (ESCC). Reverse transcription-polymerase chain reaction and fluorescence in situ hybridization (FISH) revealed upregulation of PLK1 mRNA and amplification of PLK1 gene, respectively. Depletion of PLK1 activated the intrinsic apoptotic pathway, which was substantiated by loss of mitochondrial membrane potential, reduction of Mcl-1 and Bcl-2 as well as activation of caspase-9. Coimmunoprecipitation and confocal microscopy displayed that PLK1 was associated with survivin and PLK1 depletion led to downregulation of survivin. Cotransfection of survivin constructs could partially reverse PLK1-depletion-induced apoptosis. These data suggest that PLK1 might be a useful prognostic marker and a potential therapeutic target for ESCC. Survivin is probably involved in antiapoptotic function of PLK1. Copyright (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19004025     DOI: 10.1002/ijc.23990

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  44 in total

1.  Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques.

Authors:  Marilanda Ferreira Bellini; Ana Elizabete Silva; Marileila Varella-Garcia
Journal:  Genet Mol Biol       Date:  2010-06-01       Impact factor: 1.771

2.  Study on the effect of IRE1a on cell growth and apoptosis via modulation PLK1 in ER stress response.

Authors:  Xiangzhu Li; Huifang Zhu; Huizhe Huang; Rong Jiang; Wenjun Zhao; Yanna Liu; Jinghua Zhou; Feng-Jin Guo
Journal:  Mol Cell Biochem       Date:  2012-06       Impact factor: 3.396

3.  Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.

Authors:  Ting-Ting Liu; Kai-Xia Yang; Jing Yu; Ying-Ya Cao; Jian-Song Ren; Jia-Jie Hao; Bei-Qing Pan; Sai Ma; Li-Yan Yang; Yan Cai; Ming-Rong Wang; Yu Zhang
Journal:  J Mol Med (Berl)       Date:  2018-06-29       Impact factor: 4.599

4.  Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.

Authors:  Chunling Zhao; Lei Gong; Wentong Li; Limei Chen
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

5.  Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors.

Authors:  Glen J Weiss; Gayle Jameson; Daniel D Von Hoff; Barbara Valsasina; Cristina Davite; Claudia Di Giulio; Francesco Fiorentini; Rachele Alzani; Patrizia Carpinelli; Alessandro Di Sanzo; Arturo Galvani; Antonella Isacchi; Ramesh K Ramanathan
Journal:  Invest New Drugs       Date:  2017-07-20       Impact factor: 3.850

6.  Association of ECRG4 with PLK1, CDK4, PLOD1 and PLOD2 in esophageal squamous cell carcinoma.

Authors:  Linwei Li; Wenyu Wang; Xiaoyan Li; Tianhui Gao
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

7.  Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase 1 inhibition.

Authors:  Jenny Ling-Yu Chen; Jo-Pai Chen; Yu-Sen Huang; Yuan-Chun Tsai; Ming-Hsien Tsai; Fu-Shan Jaw; Jason Chia-Hsien Cheng; Sung-Hsin Kuo; Ming-Jium Shieh
Journal:  Strahlenther Onkol       Date:  2016-03-07       Impact factor: 3.621

Review 8.  Study of apoptosis-related interactions in colorectal cancer.

Authors:  Himanshu Arora; Rehana Qureshi; M A Rizvi; Sharad Shrivastava; Mordhwaj S Parihar
Journal:  Tumour Biol       Date:  2016-09-15

9.  Liaisons between survivin and Plk1 during cell division and cell death.

Authors:  Rita Colnaghi; Sally P Wheatley
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

10.  The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity.

Authors:  Yuan Zhang; Yu Liu; Yuan-Xian Yang; Jia-Hong Xia; Hong-Xiu Zhang; Hua-Bin Li; Chun-Zhao Yu
Journal:  J Exp Clin Cancer Res       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.